Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.
about
A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease.Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa doseThe effect of tolcapone on the pharmacokinetics of benserazide.
P2860
Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Pharmacodynamics of benserazid ...... ous levodopa pharmacokinetics.
@en
type
label
Pharmacodynamics of benserazid ...... ous levodopa pharmacokinetics.
@en
prefLabel
Pharmacodynamics of benserazid ...... ous levodopa pharmacokinetics.
@en
P2093
P1476
Pharmacodynamics of benserazid ...... ous levodopa pharmacokinetics.
@en
P2093
Crevoisier C
Dingemanse J
Kleinbloesem CH
P356
10.1046/J.1365-2125.1997.00610.X
P407
P577
1997-07-01T00:00:00Z